spinal muscular atrophy therapeutics (SMA project/National Institute of Neurological Disorders and Stroke)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namespinal muscular atrophy therapeutics (SMA project/National Institute of Neurological Disorders and Stroke)

Drug Alias Namesurvival motor neuron protein stimulators (SMA project/NINDS/RTI)indoprofen analogs (SMA project/NINDS/Research Triangle Institute/NIH OTT)ALB-111

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSurvival motor neuron protein stimulants

TargetsSurvival motor neuron protein

Therapy Area/IndicationsMuscular Atrophy, Spinal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Neurological Disorders And Stroke

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institutes Of Health National Institute Of Neurological Disorders And Stroke

Active IndicationsN/A

Inactive IndicationsMuscular Atrophy, Spinal

Other Information

ATC CodeN/A